MDDI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

2014 Medtech Company of the Year Finalists: Illumina

Illumina Illumina made big news earlier this year when it announced it had achieved what many had thought was inconceivable: the $1,000 genome.

Illumina

Illumina says its HiSeq X Ten can sequence an entire human genome for $1,000. 

Illumina made big news earlier this year when it announced it had achieved what many had thought was inconceivable: the $1,000 genome.

Some are skeptical that Illumina’s next-generation sequencer, the HiSeq X Ten, will truly be able to sequence a whole human genome at that price, arguing that only a few high-volume sequencers would be able to achieve that low cost. Still, it is a remarkable feat; just 13 years ago it took $100 million to sequence the human genome, according to the National Human Genome Research Institute.

San Diego–based Illumina holds a commanding share of the sequencing market and is also making strides in using genomics to further the nascent field of personalized medicine. In August, the company announced it was entering into strategic partnerships with pharmaceutical companies AstraZeneca and Sanofi as well as Janssen Biotech to develop an oncology test system that would be used for “clinical trials of targeted cancer therapies with a goal of developing and commercializing a multi-gene panel for therapeutic selection.”

   

 

[image courtesy of ILLUMINA]

Filed Under
500 characters remaining